D Kotz1, J A Stapleton, L Owen, R West. 1. Department of General Practice, CAPHRI School for Public Health and Care, Maastricht University Medical Centre, PO Box 616, 6200 MD Maastricht, The Netherlands. d.kotz@hag.unimaas.nl
Abstract
OBJECTIVE: To obtain a more rigorous estimate of the cost-effectiveness of No Smoking Day (NSD), an annual UK-wide campaign to encourage smokers to quit, than has been possible hitherto. DESIGN: Comparison of reported quit attempts in the month following NSD for three consecutive years with adjacent months using repeated national surveys of quit attempts. SETTING: England. PARTICIPANTS: A total of 1309 adults who had smoked in the past year who responded to the surveys in the month following NSD (April 2007-2009) and a comparison group of 2672 adults who smoked in the past year who responded to the survey in the two adjacent months (March and May 2007-2009). MAIN OUTCOME MEASURES: The number of additional smokers who quit permanently in response to NSD was estimated from the survey results. The incremental cost-effectiveness ratio (ICER) was calculated by combining this estimate with established estimates of life years gained and the known costs of NSD. RESULTS: The rate of quit attempts was 2.8 percentage points higher in the months following NSD (120/1309) compared with the adjacent months (170/2672; 95% CI 0.99% to 4.62%), leading to an estimated additional 0.07% of the 8.5 million smokers in England quitting permanently in response to NSD. The cost of NSD per smoker was £ 0.088. The discounted life years gained per smoker in the modal age group 35-44 years was 0.00107, resulting in an ICER of £ 82.24 (95% CI 49.7 to 231.6). ICER estimates for other age groups were similar. CONCLUSIONS: NSD emerges as an extremely cost-effective public health intervention.
OBJECTIVE: To obtain a more rigorous estimate of the cost-effectiveness of No Smoking Day (NSD), an annual UK-wide campaign to encourage smokers to quit, than has been possible hitherto. DESIGN: Comparison of reported quit attempts in the month following NSD for three consecutive years with adjacent months using repeated national surveys of quit attempts. SETTING: England. PARTICIPANTS: A total of 1309 adults who had smoked in the past year who responded to the surveys in the month following NSD (April 2007-2009) and a comparison group of 2672 adults who smoked in the past year who responded to the survey in the two adjacent months (March and May 2007-2009). MAIN OUTCOME MEASURES: The number of additional smokers who quit permanently in response to NSD was estimated from the survey results. The incremental cost-effectiveness ratio (ICER) was calculated by combining this estimate with established estimates of life years gained and the known costs of NSD. RESULTS: The rate of quit attempts was 2.8 percentage points higher in the months following NSD (120/1309) compared with the adjacent months (170/2672; 95% CI 0.99% to 4.62%), leading to an estimated additional 0.07% of the 8.5 million smokers in England quitting permanently in response to NSD. The cost of NSD per smoker was £ 0.088. The discounted life years gained per smoker in the modal age group 35-44 years was 0.00107, resulting in an ICER of £ 82.24 (95% CI 49.7 to 231.6). ICER estimates for other age groups were similar. CONCLUSIONS:NSD emerges as an extremely cost-effective public health intervention.
Authors: Jamie Brown; Daniel Kotz; Susan Michie; John Stapleton; Matthew Walmsley; Robert West Journal: Drug Alcohol Depend Date: 2013-11-20 Impact factor: 4.492
Authors: Ratna Sohanpal; Carol Rivas; Liz Steed; Virginia MacNeill; Valerie Kuan; Elizabeth Edwards; Chris Griffiths; Sandra Eldridge; Stephanie Taylor; Robert Walton Journal: BMJ Open Date: 2016-07-07 Impact factor: 2.692